Sectors & IndustriesHealthcareMedical Distribution

Best Medical Distribution Stocks to Buy Now (2026)

Top medical distribution stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best medical distribution stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical distribution stocks to buy right now are:

Cardinal Health (NYSE:CAH) is the #1 top medical distribution stock out of 10 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Cardinal Health (NYSE:CAH) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Cardinal Health (NYSE:CAH) has a Due Diligence Score of 33, which is 7 points higher than the medical distribution industry average of 26.

CAH passed 12 out of 38 due diligence checks and has average fundamentals. Cardinal Health has seen its stock return 43% over the past year, overperforming other medical distribution stocks by 30 percentage points.

Cardinal Health has an average 1 year price target of $244.22, an upside of 1.88% from Cardinal Health's current stock price of $239.71.

Cardinal Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Cardinal Health, 66.67% have issued a Strong Buy rating, 22.22% have issued a Buy, 11.11% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Cencora (NYSE:COR) is the #2 top medical distribution stock out of 10 with a Zen Rating of C. Stocks with a rating of C have had an average return of +5.11% per year. Learn more.

The Component Grade breakdown for Cencora (NYSE:COR) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: B, Financials: C, and AI: C.

Cencora (NYSE:COR) has a Due Diligence Score of 40, which is 14 points higher than the medical distribution industry average of 26.

COR passed 14 out of 38 due diligence checks and has average fundamentals. Cencora has seen its stock return 0.65% over the past year, underperforming other medical distribution stocks by -12 percentage points.

Cencora has an average 1 year price target of $363.10, an upside of 19.25% from Cencora's current stock price of $304.48.

Cencora stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Cencora, 70% have issued a Strong Buy rating, 20% have issued a Buy, 10% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Henry Schein (NASDAQ:HSIC) is the #3 top medical distribution stock out of 10 with a Zen Rating of C. Stocks with a rating of C have had an average return of +5.11% per year. Learn more.

The Component Grade breakdown for Henry Schein (NASDAQ:HSIC) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: A, Financials: C, and AI: C.

Henry Schein (NASDAQ:HSIC) has a Due Diligence Score of 27, which is 1 points higher than the medical distribution industry average of 26.

HSIC passed 9 out of 33 due diligence checks and has average fundamentals. Henry Schein has seen its stock return 18.23% over the past year, overperforming other medical distribution stocks by 5 percentage points.

Henry Schein has an average 1 year price target of $89.46, an upside of 3.01% from Henry Schein's current stock price of $86.84.

Henry Schein stock has a consensus Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Henry Schein, 27.27% have issued a Strong Buy rating, 27.27% have issued a Buy, 36.36% have issued a hold, while 0% have issued a Sell rating, and 9.09% have issued a Strong Sell.

Out of 3 medical distribution stocks that have issued dividends in the past year, the 3 medical distribution stocks with the highest dividend yields are:

Cardinal Health (NYSE:CAH) has an annual dividend yield of 0.85%, which is the same as the medical distribution industry average of 0.68%. Cardinal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cardinal Health's dividend has shown consistent growth over the last 10 years.

Cardinal Health's dividend payout ratio of 31.1% indicates that its dividend yield is sustainable for the long-term.

Cencora (NYSE:COR) has an annual dividend yield of 0.77%, which is the same as the medical distribution industry average of 0.68%. Cencora's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cencora's dividend has shown consistent growth over the last 10 years.

Cencora's dividend payout ratio of 17.5% indicates that its dividend yield is sustainable for the long-term.

Mckesson (NYSE:MCK) has an annual dividend yield of 0.41%, which is the same as the medical distribution industry average of 0.68%. Mckesson's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Mckesson's dividend has shown consistent growth over the last 10 years.

Mckesson's dividend payout ratio of 8.2% indicates that its dividend yield is sustainable for the long-term.

Medical distribution stocks were up 2.17% in the last day, and up 5.68% over the last week.

We couldn't find a catalyst for why medical distribution stocks are up.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical distribution stocks right now are:

Accendra Health (NYSE:ACH) is the most undervalued medical distribution stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Accendra Health has a valuation score of 0, which is -11 points higher than the medical distribution industry average of 11. It passed 0 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates ACH a Valuation Rating of "B".

Accendra Health's stock has dropped -62.82% in the past year. It has underperformed other stocks in the medical distribution industry by -76 percentage points.

Henry Schein (NASDAQ:HSIC) is the second most undervalued medical distribution stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Henry Schein has a valuation score of 14, which is 3 points higher than the medical distribution industry average of 11. It passed 1 out of 7 valuation due diligence checks.

Henry Schein's stock has gained 18.23% in the past year. It has overperformed other stocks in the medical distribution industry by 5 percentage points.

Mckesson (NYSE:MCK) is the third most undervalued medical distribution stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Mckesson has a valuation score of 14, which is 3 points higher than the medical distribution industry average of 11. It passed 1 out of 7 valuation due diligence checks.

Mckesson's stock has gained 9.79% in the past year. It has underperformed other stocks in the medical distribution industry by -3 percentage points.

57.14% of medical distribution stocks rated by analysts are a buy right now. On average, analysts expect medical distribution stocks to rise by 14.63% over the next year.

20% of medical distribution stocks have a Zen Rating of A (Strong Buy), 0% of medical distribution stocks are rated B (Buy), 80% are rated C (Hold), 0% are rated D (Sell), and 0% are rated F (Strong Sell).